it causes stroke and dementia as well as mood disturbance. svd increases with age but is accelerated by hypertension and diabetes.
.
.
"the drug must be administered at the right time point during development," he said.
.
harvard medical school: "cgrp: a new era for migraine treatment."
.
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
amb. macharia kamau
.
to ensure conscientious dialogue we have implemented a strict no-bullying policy. to participate, you must follow our
.